MedTrace Logo

To Study The Influence Of Genomic Factors On Metabolism And Effects Of Clomiphene In Asian Normogonadotrophic Anovulatory Patients.

NCT02548039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 124

Last updated 2018-08-07

No results posted yet for this study

Summary

The purpose of this study is to match the genetic component and clinical attributes of anovulatory patients with response to clomiphene treatment.

By improving our understanding on patient-specific clomiphene response will allow optimization of treatment, reduction of side-effects and shorten the time-to-pregnancy.

Conditions

  • Infertility, Female

Sponsors & Collaborators

  • National Cancer Centre, Singapore

    collaborator OTHER

  • KK Women's and Children's Hospital

    lead OTHER_GOV

Principal Investigators

  • Jerry Chan, MB BCh BaO (Hons) MA,FRCOG,PhD · KK Women's and Children's Hospital

Eligibility

Min Age
21 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-03-31
Completion
2018-05-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02548039 on ClinicalTrials.gov